Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc

Grade Last Price % Change Price Change
F 4.300 2.63% 0.110
EPRX closed up 1.45 percent on Wednesday, March 27, 2024, on 1.18 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 2.63%
Oversold Stochastic Weakness 2.63%
NR7 Range Contraction 4.12%
Narrow Range Bar Range Contraction 4.12%
Stochastic Reached Oversold Weakness 4.12%
Wide Bands Range Expansion 4.12%
Down 3 Days in a Row Weakness 4.12%
Oversold Stochastic Weakness 4.12%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%

   Recent Intraday Alerts

Alert Time
Up 2% about 3 hours ago
Up 1% about 3 hours ago
Fell Below Previous Day's Low about 6 hours ago
Down 1% about 6 hours ago
Rose Above Previous Day's High 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eupraxia Pharmaceuticals Inc Description

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pain Life Sciences Arthritis Osteoarthritis Skeletal Disorders

Is EPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.1
52 Week Low 3.89
Average Volume 62,470
200-Day Moving Average 6.579
50-Day Moving Average 5.792
20-Day Moving Average 4.980
10-Day Moving Average 4.346
Average True Range 0.341
RSI (14) 32.89
ADX 33.94
+DI 20.079
-DI 38.088
Chandelier Exit (Long, 3 ATRs) 6.196
Chandelier Exit (Short, 3 ATRs) 4.914
Upper Bollinger Bands 6.749
Lower Bollinger Band 3.210
Percent B (%b) 0.28
BandWidth 71.055
MACD Line -0.551
MACD Signal Line -0.508
MACD Histogram -0.043
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.565
Resistance 3 (R3) 4.593 4.497 4.503
Resistance 2 (R2) 4.497 4.401 4.483 4.482
Resistance 1 (R1) 4.343 4.342 4.420 4.315 4.461
Pivot Point 4.247 4.247 4.285 4.233 4.247
Support 1 (S1) 4.093 4.151 4.170 4.065 3.919
Support 2 (S2) 3.997 4.092 3.983 3.898
Support 3 (S3) 3.843 3.997 3.878
Support 4 (S4) 3.815